We are live on ! Find out more
BC

Bayforest Capital Portfolio holdings

AUM $108M
1-Year Est. Return 45.71%
This Fund
S&P 500
This Quarter Est. Return
+20.52%
1 Year Est. Return
+45.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$108M
AUM Growth
+$18.9M
Cap. Flow
+$8.76M
Cap. Flow %
8.1%
Top 10 Hldgs %
4.61%
Holding
1,251
New
372
Increased
261
Reduced
273
Closed
334

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$1.02M
2
ROKU icon
Roku
ROKU
+$464K
3
NTRS icon
Northern Trust
NTRS
+$442K
4
SONY icon
Sony
SONY
+$421K
5
ARCB icon
ArcBest
ARCB
+$417K

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 15.35%
3 Industrials 14.34%
4 Consumer Discretionary 13.22%
5 Financials 12.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JXN icon
26
Jackson Financial
JXN
$9.52B
$373K 0.34%
3,642
+3,393
+1,363% +$368K
AKR icon
27
Acadia Realty Trust
AKR
$2.79B
$371K 0.34%
17,747
+16,255
+1,089% +$348K
BEAM icon
28
Beam Therapeutics
BEAM
$3.06B
$369K 0.34%
+10,740
New +$324K
BMNR
29
BitMine Immersion Technologies
BMNR
$15.1B
$368K 0.34%
+27,656
New +$535K
PFG icon
30
Principal Financial Group
PFG
$25B
$367K 0.34%
3,406
+3,350
+5,982% +$340K
PAGS icon
31
PagSeguro Digital
PAGS
$2.68B
$364K 0.34%
40,237
+27,196
+209% +$263K
IRM icon
32
Iron Mountain
IRM
$34.8B
$364K 0.34%
2,882
+406
+16% +$49.8K
PHIN icon
33
Phinia Inc
PHIN
$2.53B
$364K 0.34%
+4,419
New +$338K
NBIS
34
Nebius Group N.V.
NBIS
$61.5B
$363K 0.34%
+1,316
New +$261K
VRDN icon
35
Viridian Therapeutics
VRDN
$2.6B
$363K 0.34%
+19,775
New +$319K
TMO icon
36
Thermo Fisher Scientific
TMO
$227B
$361K 0.33%
721
+628
+675% +$301K
GFF icon
37
Griffon
GFF
$4.51B
$358K 0.33%
3,669
+3,377
+1,157% +$295K
CRL icon
38
Charles River Laboratories
CRL
$13.8B
$356K 0.33%
1,570
+1,360
+648% +$242K
APGE icon
39
Apogee Therapeutics
APGE
$355K 0.33%
2,674
-3,389
-56% -$305K
LAUR icon
40
Laureate Education
LAUR
$5.06B
$355K 0.33%
9,762
+9,212
+1,675% +$311K
VST icon
41
Vistra
VST
$50.1B
$346K 0.32%
+2,180
New +$338K
VEEV icon
42
Veeva Systems
VEEV
$44.5B
$345K 0.32%
+1,943
New +$320K
SAIC icon
43
Saic
SAIC
$5.31B
$342K 0.32%
+3,094
New +$313K
COCO icon
44
Vita Coco
COCO
$3.19B
$341K 0.32%
+5,158
New +$348K
EXC icon
45
Exelon
EXC
$45B
$338K 0.31%
7,240
+5,418
+297% +$251K
AES icon
46
AES
AES
$10.6B
$337K 0.31%
22,991
+8,914
+63% +$130K
KBR icon
47
KBR
KBR
$4.64B
$335K 0.31%
9,691
+5,707
+143% +$199K
CBRL icon
48
Cracker Barrel
CBRL
$1.22B
$333K 0.31%
6,256
+2,313
+59% +$80.1K
DXC icon
49
DXC Technology
DXC
$1.86B
$332K 0.31%
37,498
+36,472
+3,555% +$378K
PTGX icon
50
Protagonist Therapeutics
PTGX
$9.43B
$328K 0.3%
+2,675
New +$279K

Similar funds

Bayforest Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Bayforest Capital held 1,251 positions worth $108M, up 21% from $89.3M the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Bayforest Capital deployed $8.76M of net new capital in Q2 2026, opening 372 new positions and adding to 261 existing holdings. Its largest new stake was Slide Insurance Holdings: 35,302 shares worth $684K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Sandisk, an estimated $1.02M trimmed.

  • Bayforest Capital's largest Q2 2026 buy was Slide Insurance Holdings: 35,302 shares worth $684K.
  • Bayforest Capital added most to Talos Energy in Q2 2026, an estimated $539K increase.
  • Bayforest Capital's biggest Q2 2026 reduction was Sandisk, cutting an estimated $1.02M.
  • Bayforest Capital fully exited Northern Trust in Q2 2026, selling an estimated $442K.
  • Bayforest Capital's ten largest holdings make up 4.6% of its $108M portfolio in Q2 2026.
  • Bayforest Capital opened 372 new positions and closed 334 in Q2 2026.
  • Bayforest Capital's portfolio value rose 21% quarter-over-quarter to $108M.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.